178 filings
8-K
RNAZ
TransCode Therapeutics Inc
23 Apr 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:00pm
8-K
RNAZ
TransCode Therapeutics Inc
5 Apr 24
TransCode Therapeutics Reports 2023 Results; Provides Business Update
4:51pm
10-K
2023 FY
RNAZ
TransCode Therapeutics Inc
Annual report
1 Apr 24
5:10pm
SC 13G/A
RNAZ
TransCode Therapeutics Inc
15 Feb 24
Transcode Therapeutics / Medarova Zdravka ownership change
4:00pm
SC 13G/A
RNAZ
TransCode Therapeutics Inc
14 Feb 24
Transcode Therapeutics / TANG CAPITAL PARTNERS ownership change
4:00pm
SC 13G/A
Lind Global Fund II LP
13 Feb 24
Transcode Therapeutics / Lind Global Fund II ownership change
8:12pm
8-K
RNAZ
TransCode Therapeutics Inc
31 Jan 24
Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market
4:33pm
8-K
RNAZ
TransCode Therapeutics Inc
22 Jan 24
TransCode Therapeutics Announces Pricing of $7.25 Million Public Offering
4:45pm
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
EFFECT
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Notice of effectiveness
12:15am
S-1/A
RNAZ
TransCode Therapeutics Inc
IPO registration (amended)
18 Jan 24
10:39am
S-1/A
RNAZ
TransCode Therapeutics Inc
IPO registration (amended)
17 Jan 24
7:06am
CORRESP
RNAZ
TransCode Therapeutics Inc
17 Jan 24
Correspondence with SEC
12:00am
CORRESP
RNAZ
TransCode Therapeutics Inc
17 Jan 24
Correspondence with SEC
12:00am
8-K
RNAZ
TransCode Therapeutics Inc
16 Jan 24
TransCode Therapeutics Announces 1-for-40 Reverse Stock Split
4:01pm
UPLOAD
RNAZ
TransCode Therapeutics Inc
16 Jan 24
Letter from SEC
12:00am
S-1
RNAZ
TransCode Therapeutics Inc
IPO registration
11 Jan 24
8:22am
8-K
RNAZ
TransCode Therapeutics Inc
8 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
RNAZ
TransCode Therapeutics Inc
4 Jan 24
Additional proxy soliciting materials
12:41pm
DEF 14A
RNAZ
TransCode Therapeutics Inc
Definitive proxy
18 Dec 23
4:28pm